Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: The Effect of Hedia Diabetes Assistant on TiMe-in-range in People With Type 1 Diabetes and Sub-Optimal Glycemic Control in France - A Randomised Controlled Trial. [NA]

View source ↗

Summary

A randomized controlled trial in France is evaluating whether the Hedia Diabetes Assistant improves time-in-range in people with Type 1 diabetes and sub-optimal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hedia Diabetes Assistant

Snippet

Sponsor: Hedia ApS | Conditions: Type 1 Diabetes Mellitus (T1DM) | NA | Status: ACTIVE_NOT_RECRUITING